Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.

Evsyukov V, Domanskyi A, Bierhoff H, Gispert S, Mustafa R, Schlaudraff F, Liss B, Parlato R.

Dis Model Mech. 2017 May 1;10(5):633-643. doi: 10.1242/dmm.028092. Epub 2017 Mar 30.

2.

Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.

Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, Fauler M, Hetzel A, Watanabe M, Lujan R, Malenka RC, Striessnig J, Liss B.

Brain. 2014 Aug;137(Pt 8):2287-302. doi: 10.1093/brain/awu131. Epub 2014 Jun 16.

3.

Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.

Schlaudraff F, Gründemann J, Fauler M, Dragicevic E, Hardy J, Liss B.

Neurobiol Aging. 2014 Oct;35(10):2302-15. doi: 10.1016/j.neurobiolaging.2014.03.016. Epub 2014 Mar 22.

4.

Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease.

Müller SK, Bender A, Laub C, Högen T, Schlaudraff F, Liss B, Klopstock T, Elstner M.

Neurobiol Aging. 2013 Sep;34(9):2231-3. doi: 10.1016/j.neurobiolaging.2013.03.016. Epub 2013 Apr 6.

PMID:
23566333
5.

K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration.

Schiemann J, Schlaudraff F, Klose V, Bingmer M, Seino S, Magill PJ, Zaghloul KA, Schneider G, Liss B, Roeper J.

Nat Neurosci. 2012 Sep;15(9):1272-80. doi: 10.1038/nn.3185. Epub 2012 Aug 19.

6.

Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions.

Elstner M, Müller SK, Leidolt L, Laub C, Krieg L, Schlaudraff F, Liss B, Morris C, Turnbull DM, Masliah E, Prokisch H, Klopstock T, Bender A.

Mol Brain. 2011 Dec 21;4:43. doi: 10.1186/1756-6606-4-43.

7.

Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction.

Sperka T, Song Z, Morita Y, Nalapareddy K, Guachalla LM, Lechel A, Begus-Nahrmann Y, Burkhalter MD, Mach M, Schlaudraff F, Liss B, Ju Z, Speicher MR, Rudolph KL.

Nat Cell Biol. 2011 Dec 4;14(1):73-9. doi: 10.1038/ncb2388.

PMID:
22138576
8.

UV-laser microdissection and mRNA expression analysis of individual neurons from postmortem Parkinson's disease brains.

Gründemann J, Schlaudraff F, Liss B.

Methods Mol Biol. 2011;755:363-74. doi: 10.1007/978-1-61779-163-5_30.

PMID:
21761319
9.

A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.

Kurz A, Double KL, Lastres-Becker I, Tozzi A, Tantucci M, Bockhart V, Bonin M, García-Arencibia M, Nuber S, Schlaudraff F, Liss B, Fernández-Ruiz J, Gerlach M, Wüllner U, Lüddens H, Calabresi P, Auburger G, Gispert S.

PLoS One. 2010 Jul 7;5(7):e11464. doi: 10.1371/journal.pone.0011464.

10.

p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice.

Begus-Nahrmann Y, Lechel A, Obenauf AC, Nalapareddy K, Peit E, Hoffmann E, Schlaudraff F, Liss B, Schirmacher P, Kestler H, Danenberg E, Barker N, Clevers H, Speicher MR, Rudolph KL.

Nat Genet. 2009 Oct;41(10):1138-43. doi: 10.1038/ng.426. Epub 2009 Aug 30.

PMID:
19718028
11.

Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.

Gründemann J, Schlaudraff F, Haeckel O, Liss B.

Nucleic Acids Res. 2008 Apr;36(7):e38. doi: 10.1093/nar/gkn084. Epub 2008 Mar 10.

12.

Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum.

Aguado C, Colón J, Ciruela F, Schlaudraff F, Cabañero MJ, Perry C, Watanabe M, Liss B, Wickman K, Luján R.

J Neurochem. 2008 Apr;105(2):497-511. Epub 2007 Dec 6. Erratum in: J Neurochem. 2008 Jun;105(5):2053-4.

Supplemental Content

Loading ...
Support Center